Related Experiment Video
Updated: Jun 4, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Cefepime-related encephalopathy in peritoneal dialysis patients
Chun-Jen Lin1, Shih-Pin Chen, Shuu-Jiun Wang
1Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, #201 Sec. 2 Shih-Pai Road, Taipei, Taiwan, ROC.
Abstract:
Encephalopathy or neurotoxicity can occur with cefepime use in patients with impaired or relatively normal renal function. However, few articles have examined the relationship between cefepime's adverse effects and peritoneal dialysis. Here, we report the case of an 80-year-old woman with chronic renal failure on peritoneal dialysis that developed agitation, confusion, and dystonia after cefepime administration for 2 days. The clinical and electroencephalographic abnormalities improved after discontinuation the drug. We review the role of peritoneal dialysis in the development of cefepime-induced encephalopathy. Peritoneal dialysis is a less efficient way to eliminate cefepime than hemodialysis. Short-term hemodialysis might be considered to facilitate elimination of the drug in patients who have developed neurotoxicity.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management
Hepatic Encephalopathy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Encephalitis l: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
